nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RASGRF1—refractive error	0.0491	0.0491	CbGpPWpGaD
Trametinib—MAP2K1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RASGRF1—refractive error	0.0459	0.0459	CbGpPWpGaD
Trametinib—MAP2K2—Hypothetical Network for Drug Addiction—GRIA4—refractive error	0.0313	0.0313	CbGpPWpGaD
Trametinib—MAP2K1—Hypothetical Network for Drug Addiction—GRIA4—refractive error	0.0293	0.0293	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—PTPRR—refractive error	0.0206	0.0206	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—PTPRR—refractive error	0.02	0.02	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—PTPRR—refractive error	0.0193	0.0193	CbGpPWpGaD
Trametinib—MAP2K1—Neurotrophic factor-mediated Trk receptor signaling—RASGRF1—refractive error	0.0188	0.0188	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—PTPRR—refractive error	0.0187	0.0187	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—AXL—refractive error	0.0165	0.0165	CbGpPWpGaD
Trametinib—MAP2K2—NCAM signaling for neurite out-growth—CACNA1D—refractive error	0.0158	0.0158	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—AXL—refractive error	0.0156	0.0156	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—AXL—refractive error	0.0154	0.0154	CbGpPWpGaD
Trametinib—MAP2K1—NCAM signaling for neurite out-growth—CACNA1D—refractive error	0.0148	0.0148	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—AXL—refractive error	0.0146	0.0146	CbGpPWpGaD
Trametinib—MAP2K2—NCAM signaling for neurite out-growth—COL9A1—refractive error	0.0144	0.0144	CbGpPWpGaD
Trametinib—MAP2K1—NCAM signaling for neurite out-growth—COL9A1—refractive error	0.0134	0.0134	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—ZEB2—refractive error	0.0128	0.0128	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—ZEB2—refractive error	0.0119	0.0119	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—RNF111—refractive error	0.0112	0.0112	CbGpPWpGaD
Trametinib—MAP2K2—mTOR signaling pathway—PML—refractive error	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—RNF111—refractive error	0.0104	0.0104	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—RASGRF1—refractive error	0.0101	0.0101	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IFITM2—refractive error	0.0101	0.0101	CbGpPWpGaD
Trametinib—MAP2K1—mTOR signaling pathway—PML—refractive error	0.00989	0.00989	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—RASGRF1—refractive error	0.00947	0.00947	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IFITM2—refractive error	0.00944	0.00944	CbGpPWpGaD
Trametinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00727	0.00727	CbGpPWpGaD
Trametinib—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00718	0.00718	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—ROBO3—refractive error	0.0068	0.0068	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—COL9A1—refractive error	0.00654	0.00654	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—BMP2—refractive error	0.00651	0.00651	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—ROBO3—refractive error	0.00636	0.00636	CbGpPWpGaD
Trametinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00615	0.00615	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—LAMA2—refractive error	0.00614	0.00614	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—COL9A1—refractive error	0.00612	0.00612	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—PML—refractive error	0.00607	0.00607	CbGpPWpGaD
Trametinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.0059	0.0059	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—LAMA2—refractive error	0.00575	0.00575	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—PML—refractive error	0.00568	0.00568	CbGpPWpGaD
Trametinib—MAP2K2—Signaling of Hepatocyte Growth Factor Receptor—PTEN—refractive error	0.00549	0.00549	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—BMP2—refractive error	0.0054	0.0054	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00529	0.00529	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—COL2A1—refractive error	0.00527	0.00527	CbGpPWpGaD
Trametinib—MAP2K1—Signaling of Hepatocyte Growth Factor Receptor—PTEN—refractive error	0.00514	0.00514	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—BMP2—refractive error	0.00506	0.00506	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—PDGFRA—refractive error	0.00495	0.00495	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—COL2A1—refractive error	0.00493	0.00493	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—ROBO3—refractive error	0.00485	0.00485	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—SALL4—refractive error	0.00463	0.00463	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—ROBO3—refractive error	0.00454	0.00454	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—CACNA1D—refractive error	0.00454	0.00454	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—SALL4—refractive error	0.00433	0.00433	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—CACNA1D—refractive error	0.00425	0.00425	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00423	0.00423	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—COL9A1—refractive error	0.00412	0.00412	CbGpPWpGaD
Trametinib—MAP2K2—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—refractive error	0.00397	0.00397	CbGpPWpGaD
Trametinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.0039	0.0039	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CER1—refractive error	0.00388	0.00388	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—COL9A1—refractive error	0.00386	0.00386	CbGpPWpGaD
Trametinib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00385	0.00385	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTEN—refractive error	0.00372	0.00372	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CER1—refractive error	0.00363	0.00363	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—OR2M7—refractive error	0.00361	0.00361	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00347	0.00347	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—PDGFRA—refractive error	0.00343	0.00343	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—OR2M7—refractive error	0.00337	0.00337	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—PML—refractive error	0.00333	0.00333	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFITM2—refractive error	0.00329	0.00329	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00328	0.00328	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00328	0.00328	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CACNA1D—refractive error	0.00324	0.00324	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—PDGFRA—refractive error	0.00323	0.00323	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—PDGFRA—refractive error	0.00321	0.00321	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00317	0.00317	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—CYP26A1—refractive error	0.00313	0.00313	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—PML—refractive error	0.00311	0.00311	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—CYP26A1—refractive error	0.00309	0.00309	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—PDGFRA—refractive error	0.00308	0.00308	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFITM2—refractive error	0.00308	0.00308	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00307	0.00307	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—PDGFRA—refractive error	0.00307	0.00307	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—PDGFRA—refractive error	0.00307	0.00307	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—VIPR2—refractive error	0.00307	0.00307	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—PDGFRA—refractive error	0.00305	0.00305	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—PDGFRA—refractive error	0.00304	0.00304	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CACNA1D—refractive error	0.00303	0.00303	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—PDGFRA—refractive error	0.00302	0.00302	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00302	0.00302	CbGpPWpGaD
Trametinib—MAP2K1—BCR signaling pathway—PTEN—refractive error	0.00299	0.00299	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—COL9A1—refractive error	0.00294	0.00294	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—PDGFRA—refractive error	0.00289	0.00289	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—PDGFRA—refractive error	0.00287	0.00287	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—VIPR2—refractive error	0.00287	0.00287	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—PDGFRA—refractive error	0.00286	0.00286	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00286	0.00286	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—PDGFRA—refractive error	0.00286	0.00286	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—PDGFRA—refractive error	0.00286	0.00286	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—PDGFRA—refractive error	0.00284	0.00284	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—PDGFRA—refractive error	0.00283	0.00283	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GREM2—refractive error	0.00281	0.00281	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00281	0.00281	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—PDGFRA—refractive error	0.0028	0.0028	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—COL9A1—refractive error	0.00275	0.00275	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00272	0.00272	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—PDGFRA—refractive error	0.0027	0.0027	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—PDGFRA—refractive error	0.00267	0.00267	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00267	0.00267	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—PDGFRA—refractive error	0.00267	0.00267	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—PDGFRA—refractive error	0.00265	0.00265	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GREM2—refractive error	0.00263	0.00263	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00263	0.00263	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—PDGFRA—refractive error	0.00262	0.00262	CbGpPWpGaD
Trametinib—MAP2K2—Disease—DSE—refractive error	0.00259	0.00259	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.00254	0.00254	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00253	0.00253	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PDGFRA—refractive error	0.00253	0.00253	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00252	0.00252	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RDH5—refractive error	0.00243	0.00243	CbGpPWpGaD
Trametinib—MAP2K1—Disease—DSE—refractive error	0.00242	0.00242	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CHN1—refractive error	0.00239	0.00239	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00237	0.00237	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—WNT10A—refractive error	0.00232	0.00232	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PCCA—refractive error	0.00231	0.00231	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RDH5—refractive error	0.00227	0.00227	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CHN1—refractive error	0.00224	0.00224	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—WNT10A—refractive error	0.00217	0.00217	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PCCA—refractive error	0.00216	0.00216	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OR2M7—refractive error	0.00213	0.00213	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IPO5—refractive error	0.00211	0.00211	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00209	0.00209	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00204	0.00204	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00204	0.00204	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RNF111—refractive error	0.002	0.002	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OR2M7—refractive error	0.00199	0.00199	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IPO5—refractive error	0.00197	0.00197	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PAX6—refractive error	0.00196	0.00196	CbGpPWpGaD
Trametinib—MAP2K2—Disease—WNT10A—refractive error	0.00196	0.00196	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PDGFRA—refractive error	0.00195	0.00195	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—PTEN—refractive error	0.00194	0.00194	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RNF111—refractive error	0.00187	0.00187	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RNF111—refractive error	0.00184	0.00184	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PAX6—refractive error	0.00184	0.00184	CbGpPWpGaD
Trametinib—MAP2K1—Disease—WNT10A—refractive error	0.00183	0.00183	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PDGFRA—refractive error	0.00182	0.00182	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—PTEN—refractive error	0.00181	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VIPR2—refractive error	0.00181	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—PTEN—refractive error	0.00176	0.00176	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RNF111—refractive error	0.00172	0.00172	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RDH5—refractive error	0.0017	0.0017	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTSC—refractive error	0.0017	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VIPR2—refractive error	0.00169	0.00169	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—PTEN—refractive error	0.00168	0.00168	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.00168	0.00168	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.00166	0.00166	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—PTEN—refractive error	0.00166	0.00166	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—PTEN—refractive error	0.00165	0.00165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AXL—refractive error	0.00161	0.00161	CbGpPWpGaD
Trametinib—MAP2K2—Disease—LUM—refractive error	0.0016	0.0016	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RDH5—refractive error	0.00159	0.00159	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—PTEN—refractive error	0.00159	0.00159	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTSC—refractive error	0.00159	0.00159	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—PTEN—refractive error	0.00157	0.00157	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—PTEN—refractive error	0.00156	0.00156	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—PTEN—refractive error	0.00155	0.00155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AXL—refractive error	0.00151	0.00151	CbGpPWpGaD
Trametinib—MAP2K1—Disease—LUM—refractive error	0.00149	0.00149	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—PTEN—refractive error	0.00149	0.00149	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—PTEN—refractive error	0.00148	0.00148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VANGL2—refractive error	0.00148	0.00148	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—PTEN—refractive error	0.00147	0.00147	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—PTEN—refractive error	0.00146	0.00146	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—PTEN—refractive error	0.00145	0.00145	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—PTEN—refractive error	0.00144	0.00144	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—PTEN—refractive error	0.00144	0.00144	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—PTEN—refractive error	0.00139	0.00139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VANGL2—refractive error	0.00138	0.00138	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—PTEN—refractive error	0.00137	0.00137	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—PTEN—refractive error	0.00137	0.00137	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00137	0.00137	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WNT10A—refractive error	0.00137	0.00137	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—PTEN—refractive error	0.00136	0.00136	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—PTEN—refractive error	0.00135	0.00135	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EBP—refractive error	0.00135	0.00135	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—PTEN—refractive error	0.00134	0.00134	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.0013	0.0013	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PTEN—refractive error	0.0013	0.0013	CbGpPWpGaD
Trametinib—MAP2K2—Disease—RPS27—refractive error	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TJP2—refractive error	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RNF111—refractive error	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CER1—refractive error	0.00129	0.00129	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WNT10A—refractive error	0.00128	0.00128	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00122	0.00122	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RPS27—refractive error	0.00121	0.00121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RNF111—refractive error	0.00121	0.00121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TJP2—refractive error	0.00121	0.00121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CER1—refractive error	0.00121	0.00121	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PDGFRA—refractive error	0.00111	0.00111	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PML—refractive error	0.00109	0.00109	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PDGFRA—refractive error	0.00104	0.00104	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DSE—refractive error	0.00102	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PML—refractive error	0.00102	0.00102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PTEN—refractive error	0.001	0.001	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—COL9A1—refractive error	0.000978	0.000978	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PTEN—refractive error	0.000936	0.000936	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—COL9A1—refractive error	0.000915	0.000915	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PCCA—refractive error	0.000909	0.000909	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PLA2G16—refractive error	0.000909	0.000909	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EBP—refractive error	0.000722	0.000722	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—BMP2—refractive error	0.00067	0.00067	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PDGFRA—refractive error	0.000647	0.000647	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LUM—refractive error	0.00063	0.00063	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—BMP2—refractive error	0.000627	0.000627	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CACNA1D—refractive error	0.000606	0.000606	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PDGFRA—refractive error	0.000605	0.000605	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PDGFRA—refractive error	0.000597	0.000597	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PTEN—refractive error	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PDGFRA—refractive error	0.000559	0.000559	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DSE—refractive error	0.000547	0.000547	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP26A1—refractive error	0.000536	0.000536	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PTEN—refractive error	0.000534	0.000534	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PCCA—refractive error	0.000488	0.000488	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PLA2G16—refractive error	0.000488	0.000488	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PDGFRA—refractive error	0.000418	0.000418	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDGFRA—refractive error	0.000391	0.000391	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LUM—refractive error	0.000338	0.000338	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—refractive error	0.000332	0.000332	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CACNA1D—refractive error	0.000325	0.000325	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—refractive error	0.000311	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—refractive error	0.000307	0.000307	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP26A1—refractive error	0.000288	0.000288	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—refractive error	0.000287	0.000287	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000272	0.000272	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—refractive error	0.000215	0.000215	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—refractive error	0.000201	0.000201	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—refractive error	0.000121	0.000121	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—refractive error	6.49e-05	6.49e-05	CbGpPWpGaD
